Wealth Enhancement Advisory Services, LLC Novartis Ag Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Novartis Ag stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 140,753 shares of NVS stock, worth $16 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
140,753
Previous 145,836
3.49%
Holding current value
$16 Million
Previous $14.2 Million
10.57%
% of portfolio
0.03%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding NVS
# of Institutions
1,504Shares Held
130MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.39 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.25 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$929 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$780 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$633 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $244B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...